The effect of repeated transfusions on active cytomegalovirus infection, in the presence of IgM, in patients with thalassemia major in Iran
暂无分享,去创建一个
[1] C. Hillyer,et al. Transfusion-transmitted cytomegalovirus: lessons from a murine model. , 2007, Transfusion medicine reviews.
[2] J. Marcello,et al. Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents , 2006, Transfusion.
[3] A. Kothari,et al. Cytomegalovirus infection in neonates following exchange transfusion , 2006, Indian journal of pediatrics.
[4] M. Blajchman,et al. The clinical benefits of the leukoreduction of blood products. , 2006, The Journal of trauma.
[5] J. Preiksaitis,et al. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. , 2006, Transfusion medicine reviews.
[6] M. Heemskerk,et al. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. , 2006, Blood.
[7] M. Lima,et al. Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients , 2005, Bone Marrow Transplantation.
[8] E. Vamvakas. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. , 2005, Transfusion medicine reviews.
[9] J. Fisk,et al. Universal pre-storage leukoreduction--A defensible use of hospital resources: the Yale-New Haven Hospital experience. , 2005, Developments in biologicals.
[10] P. Ljungman,et al. Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors , 2002, Scandinavian journal of infectious diseases.
[11] L. Kalish,et al. WBC reduction in RBC concentrates by prestorage filtration: multicenter experience , 2001, Transfusion.
[12] C. Hillyer,et al. Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections , 2000, Transfusion.
[13] M. Naveed,et al. Serological monitoring of thalassaemia major patients for transfusion associated viral infections. , 1998, The Indian journal of medical research.
[14] N. Pavlides,et al. Transfusional transmitted viruses in pregnancy. , 1998, Journal of pediatric endocrinology & metabolism : JPEM.
[15] L. Williamson,et al. Leucodepletion of blood products by filtration. , 1995, Blood reviews.
[16] T. Vergheese,et al. Role of transfusion-mediated viral infections on the lymphocyte subset profile in multi-transfused children. , 1993, Journal of tropical pediatrics.
[17] P. Lionetti,et al. Viral infections in transfusion‐dependent patients with beta‐ thalassemia major: the predominant role of cytomegalovirus , 1990, Transfusion.
[18] G. Lucarelli,et al. Cytomegalovirus infections in thalassemic patients after bone marrow transplantation. , 1990, Bone marrow transplantation.
[19] K. Hsieh,et al. Immunologic and virologic status of multitransfused thalassemic patients. , 1990, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology.
[20] J. Gray,et al. Viral Infections , 2010, Small Animal Pediatrics.
[21] A. Germenis,et al. Thalassemic patients are at high risk for transfusion-transmitted cytomegalovirus infections. , 1989, Acta haematologica.
[22] M. Smith,et al. The transmission of infections. , 1954, Pediatrics.